Pardee, T. S., Maher, K. R., Burkart, M., Wieduwilt, M. J., Lyerly, S., Dralle, S., Manuel, M., Ellis, L. R., Howard, D., Bhave, R. R., Powell, B. L. (2026). A randomized phase II study of selinexor added to standard induction and consolidation chemotherapy in adults with acute myeloid leukemia (AML).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.6512